BTG Share PerformanceMore
|52 week high||784.0 28/12/17|
|52 week low||528.4 31/01/17|
|52 week change||158.0 (26.83%)|
|4 week volume||10,776,858 25/12/17|
Latest News« previous» nextMore
02/01/2018 - 11:01 RNS
RNS Number: 7086A BTG PLC 02 January 2018 2 January 2018 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 2 January 2018: 1. the Company's issued share capital consists of 386,435,712 Ordinaryshares of 10p each admitted to trading, and each with one vo...
07/12/2017 - 08:00 StockMarketWire
BTG, the specialist healthcare company, will host an interventional medicine seminar today at the offices of Deutsche Ban...
07/12/2017 - 07:00 RNS
RNS Number: 4151Y BTG PLC 07 December 2017 BTG plc: Interventional Medicine Seminar London, UK, 7 December 2017: BTG plc (LSE: BTG), the specialist healthcare company, will host an Interventional Medicine Seminar today at 10:30am at the offices of Deutsche Bank, 1 Great Winchester Street, London, EC3N 2DB. This event will provide greater understanding...
01/12/2017 - 09:59 RNS
RNS Number: 1317Y BTG PLC 01 December 2017 1 December 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 1 December 2017: 1. the Company's issued share capital consists of 386,413,796 Ordinaryshares of 10p each admitted to trading, and each with on...
27/11/2017 - 09:20 StockMarketWire
BTG, the global specialist healthcare company, has appointed Gregory Barrett as a non-executive director. Barrett is curren...
27/11/2017 - 07:00 RNS
RNS Number: 5273X BTG PLC 27 November 2017 BTG plc: Appointment of Non-executive Director London, UK, 27 November 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces the appointment of Gregory Barrett as a non-executive director of the Board. Greg has a broad range of commercial experience in the US medtech indus...
22/11/2017 - 10:40 StockMarketWire
JP Morgan Cazenove today reaffirms its neutral investment rating on BTG PLC (LON:BTG) and cut its price target to 730...
16/11/2017 - 16:37 RNS
RNS Number: 7612W BTG PLC 16 November 2017 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: BTG PLC LEI: 213800DCVRNVRVINH968 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Re...
|Dividend yield||0 %|
Latest discussion posts More
“As far as I know is that this university Hospital have been trialling the product and as I understand it they concluded it gives greater life expectancy than the present ...”▼
“Hi DG, thanks for that. Any idea how important this is in the wider adoption of Theraspere as a treatment?”▼
“administrative court invalidated a Johnson & Johnson (JNJ.N) patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and ...”▼
Codes & Symbols
|Symbols||BTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment